Peri-implantitis Market

Global Peri-implantitis Market by Method Types (Surgical [Bone Regeneration, Open Flap Debridement, and Implantoplasty] and Non-surgical [Mechanical Debridement, Laser Debridement, Antibiotics, and Others]), End-users (Hospitals, Dental Clinics, and Others), and Regions (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa), Forecasts 2021-2028

  • Report ID: HC-3258
  • Author: Growth Market Reports
  • Rating: 4.8
  • Total Reviews: 2
  • No. Of Pages: 174
  • Format:
  • Pub. Date: Upcoming
  • Share:

The global peri-implantitis market is expected to reach USD 1.3 billion by 2028, expanding at a CAGR of 8.7% during the forecast period, 2021-2028. Peri-implantitis is a contagious disease that causes soft tissue inflammation and bone deterioration near the function of an Osseo integrated implant. Dental implants are an attempted therapy for replacing damaged teeth in a medical surgical. The most common symptoms of peri-implantitis include severe toothache, gum pain, the sensation that the implant is loose, and irritation Smoking, poor oral hygiene, a history of periodontitis, biomechanical overload that leads to high stress and micro-fractures causing loss of osseointegration around the neck of the implant, poor quality bone, incorrect implant position, implant overloading, and diabetes are all major risk factors for peri-implantitis. Peri-implantitis is categorized into four stages based on the amount of bone loss in the implanted teeth. The dentist determines the treatment aim based on the degree of osseous involvement, which includes halting disease development, regeneration, and replacement.

Peri-implantitis Market key takeaways

Market Trends, Drivers, Restraints, and Opportunities

  • Growing demand for dental implants, and increased awareness of diseases associated with dental implants are major factors expected to drive the growth of the peri-implantitis market.
  • Technological advancements is estimated to propel the growth of the market. For instance, mechanical debridement combined with laser decontamination, surgical debridement with guided bone regeneration (GBR) for bony and soft-tissue repair, and diagnostic genetic biomarker approaches have improved clinical results and selective calculus removal.
  • Lack of information, high surgical costs, and government regulation situations are some of the factors that are expected to restrain demand growth during the forecast period.
  • Increasing incidence of oral disorders is anticipated to spur the market growth in the projected timeline.

Scope of the report

The report on the global peri-implantitis market includes an assessment of the market scope, analysis, share, competitive analysis, growth facts, restraints, opportunities, and revenue forecast.

Attributes

Details

Report Title

Peri-implantitis Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2020

Historic Data

2018–2019

Forecast Period

2021–2028

Segmentation

Method Types (Surgical [Bone Regeneration, Open Flap Debridement, and Implantoplasty] and Non-surgical [Mechanical Debridement, Laser Debridement, Antibiotics, and Others]), End-users (Hospitals, Dental Clinics, and Others)

Regional Scope

Asia Pacific, North America, Latin America, Europe, and Middle East & Africa

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast

Key Players Covered in the Report

Geistlich Pharma Inc., R.N, Laboratories Pvt. Ltd.; Basic Pharma Life Science pvt ltd., Cadila Pharmaceuticals, Prachi Pharmaceuticals Private limited, Pfizer Inc., Healthy Life Pharma

 

Peri-implantitis Market Segment insights

Surgical segment to constitute a significant market share

On the basis of method types, the market can be bifurcated into surgical and non-surgical. The surgical segment can be further segmented into bone regeneration, open flap debridement, and implantoplasty. The non-surgical segment can be sub-segmented into mechanical debridement, laser debridement, antibiotics, and others. The surgical segment is anticipated to hold a large market share during the forecast period. Surgical method provides extensive debridement and cleaning of the damaged implant. This approach is regarded as the gold standard for treating peri-implantitis. The bone regeneration sub-segment, commonly known as resective surgery, is expected to grow at a robust rate during the forecast period owing to the technique's favorable treatment outcomes in the treatment of peri-implantitis around implants. The laser debridement sub-segment is expected to exhibit a high CAGR during the forecast period, as lasers can easily address small portions of the implant surface that mechanical methods cannot reach. Er:YAG (Erbium-Doped Yttrium Aluminum Garnet), CO2 (Carbon Dioxide Laser), and diode lasers clinically significant reduces pocket-probing depth and increases clinical attachment level, as well as full bacterial elimination. These non-surgical procedures are gaining preference as they are non-invasive, require shorter recovery time, and have fewer problems.

Dental clinics segment is expected to hold a large market share

In terms of end-users, the market can be segmented into hospitals, dental clinics, and others. The dental clinics segment is estimated to account for a major market share during the forecast period. Rising preference among patients for clinics owing to high-quality care is driving the segment growth.

Peri-implantitis Market by end users

Europe estimated to dominate the market

Based on regions, the market can be classified as North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Europe is anticipated to dominate the market due to increasing patient population with periodontal diseases, technical breakthroughs, and expanding public awareness regarding dental implants and related disease. Dental implants and related therapies are covered by European National Health Services for individuals suffering from serious periodontal diseases that impair the supporting structures of teeth.

Segments

Segments covered in the report

By Method Types

  • Surgical
    • Bone Regeneration
    • Open Flap Debridement
    • Implantoplasty
  • Non-Surgical
    • Mechanical Debridement
    • Laser Debridement
    • Antibiotics
    • Others
By End-users
  • Hospitals
  • Dental Clinics
  • Others
By Regions
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
By Key Players
  • Geistlich Pharma Inc.
  • R.N
  • Laboratories Pvt. Ltd.
  • Basic Pharma Life Science pvt ltd.
  • Cadila Pharmaceuticals
  • Prachi Pharmaceuticals Private limited
  • Pfizer Inc.
  • Healthy Life Pharma

 

Competitive Landscape

The key players of the market includes Geistlich Pharma Inc., R.N, Laboratories Pvt. Ltd.; Basic Pharma Life Science pvt ltd., Cadila Pharmaceuticals, Prachi Pharmaceuticals Private limited, Pfizer Inc., Healthy Life Pharma. One of the key factors boosting market participants' competition is the rapid growth of technology in the development of anti-infective medications and treatments. Furthermore, several corporations are collaborating to develop pharmaceuticals in order to get their products to market faster. For instance, in January 2017, Pfizer invested around USD 1.0 billion for the development and commercialization rights to AstraZeneca's small molecule anti-invectives business, largely outside the US.

Peri-implantitis Market by key players

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Peri-implantitis Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Peri-implantitis Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Peri-implantitis Market - Supply Chain
  4.5. Global Peri-implantitis Market Forecast
     4.5.1. Peri-implantitis Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Peri-implantitis Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Peri-implantitis Market Absolute $ Opportunity
5. Global Peri-implantitis Market Analysis and Forecast by End Users
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by End Users
     5.2.2. Y-o-Y Growth Projections by End Users
  5.3. Peri-implantitis Market Size and Volume Forecast by End Users
     5.3.1. Hospitals
     5.3.2. Dental Clinics
     5.3.3. Others
  5.4. Absolute $ Opportunity Assessment by End Users
  5.5. Market Attractiveness/Growth Potential Analysis by End Users
6. Global Peri-implantitis Market Analysis and Forecast by Region
  6.1. Market Trends
  6.2. Introduction
     6.2.1. Basis Point Share (BPS) Analysis by Region
     6.2.2. Y-o-Y Growth Projections by Region
  6.3. Peri-implantitis Market Size and Volume Forecast by Region
     6.3.1. North America
     6.3.2. Latin America
     6.3.3. Europe
     6.3.4. Asia Pacific
     6.3.5. Middle East and Africa (MEA)
  6.4. Absolute $ Opportunity Assessment by Region
  6.5. Market Attractiveness/Growth Potential Analysis by Region
  6.6. Global Peri-implantitis Demand Share Forecast, 2019-2026
7. North America Peri-implantitis Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
  7.2. North America Peri-implantitis Market Size and Volume Forecast by Country
     7.2.1. U.S.
     7.2.2. Canada
  7.3. Absolute $ Opportunity Assessment by Country
  7.4. North America Peri-implantitis Market Size and Volume Forecast by End Users
     7.4.1. Hospitals
     7.4.2. Dental Clinics
     7.4.3. Others
  7.5. Basis Point Share (BPS) Analysis by End Users
  7.6. Y-o-Y Growth Projections by End Users
  7.7. Market Attractiveness/Growth Potential Analysis
     7.7.1. By Country
     7.7.2. By Product Type
     7.7.3. By Application
  7.8. North America Peri-implantitis Demand Share Forecast, 2019-2026
8. Latin America Peri-implantitis Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Latin America Average Pricing Analysis
  8.2. Latin America Peri-implantitis Market Size and Volume Forecast by Country
      8.2.1. Brazil
      8.2.2. Mexico
      8.2.3. Rest of Latin America
   8.3. Absolute $ Opportunity Assessment by Country
  8.4. Latin America Peri-implantitis Market Size and Volume Forecast by End Users
     8.4.1. Hospitals
     8.4.2. Dental Clinics
     8.4.3. Others
  8.5. Basis Point Share (BPS) Analysis by End Users
  8.6. Y-o-Y Growth Projections by End Users
  8.7. Market Attractiveness/Growth Potential Analysis
     8.7.1. By Country
     8.7.2. By Product Type
     8.7.3. By Application
  8.8. Latin America Peri-implantitis Demand Share Forecast, 2019-2026
9. Europe Peri-implantitis Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Europe Average Pricing Analysis
  9.2. Europe Peri-implantitis Market Size and Volume Forecast by Country
     9.2.1. Germany
     9.2.2. France
     9.2.3. Italy
     9.2.4. U.K.
     9.2.5. Spain
     9.2.6. Russia
     9.2.7. Rest of Europe
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Europe Peri-implantitis Market Size and Volume Forecast by End Users
     9.4.1. Hospitals
     9.4.2. Dental Clinics
     9.4.3. Others
  9.5. Basis Point Share (BPS) Analysis by End Users
  9.6. Y-o-Y Growth Projections by End Users
  9.7. Market Attractiveness/Growth Potential Analysis
     9.7.1. By Country
     9.7.2. By Product Type
     9.7.3. By Application
  9.8. Europe Peri-implantitis Demand Share Forecast, 2019-2026
10. Asia Pacific Peri-implantitis Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Asia Pacific Average Pricing Analysis
  10.2. Asia Pacific Peri-implantitis Market Size and Volume Forecast by Country
     10.2.1. China
     10.2.2. Japan
     10.2.3. South Korea
     10.2.4. India
     10.2.5. Australia
     10.2.6. Rest of Asia Pacific (APAC)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Asia Pacific Peri-implantitis Market Size and Volume Forecast by End Users
     10.4.1. Hospitals
     10.4.2. Dental Clinics
     10.4.3. Others
  10.5. Basis Point Share (BPS) Analysis by End Users
  10.6. Y-o-Y Growth Projections by End Users
  10.7. Market Attractiveness/Growth Potential Analysis
     10.7.1. By Country
     10.7.2. By Product Type
     10.7.3. By Application
  10.8. Asia Pacific Peri-implantitis Demand Share Forecast, 2019-2026
11. Middle East & Africa Peri-implantitis Market Analysis and Forecast
  11.1. Introduction
     11.1.1. Basis Point Share (BPS) Analysis by Country
     11.1.2. Y-o-Y Growth Projections by Country
     11.1.3. Middle East & Africa Average Pricing Analysis
  11.2. Middle East & Africa Peri-implantitis Market Size and Volume Forecast by Country
     11.2.1. Saudi Arabia
     11.2.2. South Africa
     11.2.3. UAE
     11.2.4. Rest of Middle East & Africa (MEA)
  11.3. Absolute $ Opportunity Assessment by Country
  11.4. Middle East & Africa Peri-implantitis Market Size and Volume Forecast by End Users
     11.4.1. Hospitals
     11.4.2. Dental Clinics
     11.4.3. Others
  11.5. Basis Point Share (BPS) Analysis by End Users
  11.6. Y-o-Y Growth Projections by End Users
  11.7. Market Attractiveness/Growth Potential Analysis
     11.7.1. By Country
     11.7.2. By Product Type
     11.7.3. By Application
  11.8. Middle East & Africa Peri-implantitis Demand Share Forecast, 2019-2026
12. Competition Landscape
  12.1. Global Peri-implantitis Market: Market Share Analysis
  12.2. Peri-implantitis Distributors and Customers
  12.3. Peri-implantitis Market: Competitive Dashboard
  12.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     12.4.1. Geistlich Pharma Inc.
     12.4.2. R.N
     12.4.3. Laboratories Pvt. Ltd.
     12.4.4. Basic Pharma Life Science pvt ltd.
     12.4.5. Cadila Pharmaceuticals
     12.4.6. Prachi Pharmaceuticals Private limited
     12.4.7. Pfizer Inc.

Segments covered in the report

By Method Types

  • Surgical
    • Bone Regeneration
    • Open Flap Debridement
    • Implantoplasty
  • Non-Surgical
    • Mechanical Debridement
    • Laser Debridement
    • Antibiotics
    • Others
By End-users
  • Hospitals
  • Dental Clinics
  • Others
By Regions
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
By Key Players
  • Geistlich Pharma Inc.
  • R.N
  • Laboratories Pvt. Ltd.
  • Basic Pharma Life Science pvt ltd.
  • Cadila Pharmaceuticals
  • Prachi Pharmaceuticals Private limited
  • Pfizer Inc.
  • Healthy Life Pharma

 

The key players of the market includes Geistlich Pharma Inc., R.N, Laboratories Pvt. Ltd.; Basic Pharma Life Science pvt ltd., Cadila Pharmaceuticals, Prachi Pharmaceuticals Private limited, Pfizer Inc., Healthy Life Pharma. One of the key factors boosting market participants' competition is the rapid growth of technology in the development of anti-infective medications and treatments. Furthermore, several corporations are collaborating to develop pharmaceuticals in order to get their products to market faster. For instance, in January 2017, Pfizer invested around USD 1.0 billion for the development and commercialization rights to AstraZeneca's small molecule anti-invectives business, largely outside the US.

Peri-implantitis Market by key players

Buy Report